French Polynesia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

Children under-5 years
Download
Value (%) Year Type Source
0 (0 - 0.50) 2014 Survey/reported WHO WPRO, Woodring J et al, 2017
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Overview

Prevalence (national)

Modelled

No data available
No data available

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

No data available

Survey/surveillance

No data available
HBV chart

Modelled

No data available

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners